DD119131A5 - - Google Patents

Info

Publication number
DD119131A5
DD119131A5 DD185553A DD18555375A DD119131A5 DD 119131 A5 DD119131 A5 DD 119131A5 DD 185553 A DD185553 A DD 185553A DD 18555375 A DD18555375 A DD 18555375A DD 119131 A5 DD119131 A5 DD 119131A5
Authority
DD
German Democratic Republic
Application number
DD185553A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of DD119131A5 publication Critical patent/DD119131A5/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD185553A 1974-04-19 1975-04-18 DD119131A5 (US08124317-20120228-C00060.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US462213A US3927197A (en) 1974-04-19 1974-04-19 Tertiary alcohol stabilized E-series prostaglandins

Publications (1)

Publication Number Publication Date
DD119131A5 true DD119131A5 (US08124317-20120228-C00060.png) 1976-04-12

Family

ID=23835600

Family Applications (1)

Application Number Title Priority Date Filing Date
DD185553A DD119131A5 (US08124317-20120228-C00060.png) 1974-04-19 1975-04-18

Country Status (23)

Country Link
US (1) US3927197A (US08124317-20120228-C00060.png)
JP (1) JPS5337408B2 (US08124317-20120228-C00060.png)
AR (1) AR213271A1 (US08124317-20120228-C00060.png)
AT (1) AT348130B (US08124317-20120228-C00060.png)
AU (1) AU470631B2 (US08124317-20120228-C00060.png)
BE (1) BE828065A (US08124317-20120228-C00060.png)
BG (1) BG35326A3 (US08124317-20120228-C00060.png)
CA (1) CA1034044A (US08124317-20120228-C00060.png)
CS (1) CS191244B2 (US08124317-20120228-C00060.png)
DD (1) DD119131A5 (US08124317-20120228-C00060.png)
DE (1) DE2516105C3 (US08124317-20120228-C00060.png)
DK (1) DK138161B (US08124317-20120228-C00060.png)
ES (1) ES436613A1 (US08124317-20120228-C00060.png)
FI (1) FI62220C (US08124317-20120228-C00060.png)
FR (1) FR2267760B1 (US08124317-20120228-C00060.png)
GB (1) GB1474852A (US08124317-20120228-C00060.png)
HU (1) HU175405B (US08124317-20120228-C00060.png)
IE (1) IE40829B1 (US08124317-20120228-C00060.png)
IL (1) IL46994A (US08124317-20120228-C00060.png)
LU (1) LU72320A1 (US08124317-20120228-C00060.png)
NL (1) NL158384B (US08124317-20120228-C00060.png)
PH (1) PH11697A (US08124317-20120228-C00060.png)
SE (1) SE428528B (US08124317-20120228-C00060.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197257A (en) * 1976-02-04 1980-04-08 The Upjohn Company 6-Keto prostaglandin derivatives
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4098805A (en) * 1977-04-11 1978-07-04 The Upjohn Company 9-deoxy-9-methylene-pgf-type amides
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
ES2142409T3 (es) * 1993-10-27 2000-04-16 Upjohn Co Prostaglandina e 1 estabilizada.
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US20050203086A1 (en) * 2004-03-04 2005-09-15 Pfizer Inc. Methods of treatment using an EP2 selective receptor agonist
US20100099640A1 (en) * 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
RU2020130837A (ru) 2018-02-21 2022-03-21 ЭйАй ТЕРАПЬЮТИКС, ИНК. Комбинационная терапия апилимодом и глутаматергическими агентами

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same

Also Published As

Publication number Publication date
LU72320A1 (US08124317-20120228-C00060.png) 1976-03-17
PH11697A (en) 1978-05-24
JPS5337408B2 (US08124317-20120228-C00060.png) 1978-10-09
IE40829B1 (en) 1979-08-29
CS191244B2 (en) 1979-06-29
ES436613A1 (es) 1977-04-16
FI751108A (US08124317-20120228-C00060.png) 1975-10-20
SE428528B (sv) 1983-07-11
DK138161B (da) 1978-07-24
SE7503723L (sv) 1975-10-20
IL46994A0 (en) 1975-06-25
AT348130B (de) 1979-01-25
ATA278875A (de) 1978-06-15
US3927197A (en) 1975-12-16
AR213271A1 (es) 1979-01-15
DE2516105A1 (de) 1975-10-23
GB1474852A (en) 1977-05-25
BE828065A (fr) 1975-10-17
DK167075A (US08124317-20120228-C00060.png) 1975-10-20
JPS50145515A (US08124317-20120228-C00060.png) 1975-11-21
AU470631B2 (en) 1976-03-25
NL7504274A (nl) 1975-10-21
NL158384B (nl) 1978-11-15
CA1034044A (en) 1978-07-04
DE2516105B2 (de) 1981-01-08
IL46994A (en) 1979-10-31
FR2267760A1 (US08124317-20120228-C00060.png) 1975-11-14
BG35326A3 (en) 1984-03-15
FR2267760B1 (US08124317-20120228-C00060.png) 1978-08-04
IE40829L (en) 1975-10-19
HU175405B (hu) 1980-07-28
DE2516105C3 (de) 1982-01-07
FI62220C (fi) 1982-12-10
FI62220B (fi) 1982-08-31
AU7987775A (en) 1976-03-25
DK138161C (US08124317-20120228-C00060.png) 1979-01-02

Similar Documents

Publication Publication Date Title
FR2267760B1 (US08124317-20120228-C00060.png)
FR2258729A1 (US08124317-20120228-C00060.png)
FR2291859B1 (US08124317-20120228-C00060.png)
FR2280844B1 (US08124317-20120228-C00060.png)
FR2278259B1 (US08124317-20120228-C00060.png)
DK416974A (US08124317-20120228-C00060.png)
FR2275007B3 (US08124317-20120228-C00060.png)
CS171079B1 (US08124317-20120228-C00060.png)
CS166592B1 (US08124317-20120228-C00060.png)
JPS50100509U (US08124317-20120228-C00060.png)
BG22203A1 (US08124317-20120228-C00060.png)
BG21353A1 (US08124317-20120228-C00060.png)
BG22732A1 (US08124317-20120228-C00060.png)
BG26152A1 (US08124317-20120228-C00060.png)
CH1107074A4 (US08124317-20120228-C00060.png)
CH1357474A4 (US08124317-20120228-C00060.png)
BG22484A1 (US08124317-20120228-C00060.png)
BG22309A1 (US08124317-20120228-C00060.png)
BG21285A1 (US08124317-20120228-C00060.png)
BG22011A1 (US08124317-20120228-C00060.png)
AU480469A (US08124317-20120228-C00060.png)
BG21805A1 (US08124317-20120228-C00060.png)
AU480209A (US08124317-20120228-C00060.png)
AU480580A (US08124317-20120228-C00060.png)
BG21632A1 (US08124317-20120228-C00060.png)